Archive
Private Healthcare Market Dominance Reveals Serious Problems
Find out how a few players dominate the private healthcare market, impacting profits and reducing competition in South Africa.
Read More
Discovery Defers Contribution Increase Until April
Discovery Health defers the 2026 contribution increase until April 1st, providing R1.5 billion in financial relief to members.
Read More
Netcare’s mental health services in high demand
Uncover the significance of Netcare’s mental health services amid rising public health concerns and demands in South Africa.
Read More
Tembisa Hospital Corruption Investigation Findings
Delve into the Tembisa Hospital corruption web, where R2 billion has been siphoned off due to healthcare fraud and rogue officials.
Read More
Health Funding Solution: Steps by National Treasury
Explore the health funding solution proposed by the National Treasury to address critical shortfalls in South Africa’s healthcare system.
Read More
A Diabetes Data Crisis is Making the Epidemic Invisible in SA
South Africa faces a diabetes data crisis, creating a blind spot in healthcare strategies and impacting millions of lives.
Read More
Global Fund Replenishment: Addressing Critical Needs
Learn why Global Fund replenishment is critical to combat AIDS, TB, and malaria amid severe health financing cuts.
Read More
Lenacapavir Access Under Scrutiny by Health Advocates
Explore the urgent call for lenacapavir access, as advocates seek equitable HIV prevention for all communities worldwide.
Read More
UNAIDS Closure Causes Outrage Among Health Advocates
Activists warn that the UNAIDS closure will critically affect HIV/AIDS progress, calling for urgent global health action.
Read More
Precision Medicine: Transforming Treatment Approaches
Discover the impact of precision medicine on mental health and oncology, offering hope through targeted therapies and treatments.
Read More
NHLS Cancer Testing Delays Outsourcing Solutions
Understanding NHLS cancer testing delays reveals a healthcare crisis. See how private sector labs are aiding in urgent testing.
Read More
Generic HIV Prevention Drug to Cost Just $40 Annually from 2027
Explore the benefits of the generic HIV prevention drug lenacapavir, set to change the landscape of global health by 2027.
Read More